SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2833That makes two posts on this board for the same deal that didn’t happen. PerhapsDewDiligence_on_SI112/3/2009
2832In an advanced stage. Press Release about ongoing Partnership negotiations in anB O Trust-12/3/2009
2831CEO DIAMYD: "Diamyd is in the final stages with a number of potential partnB O Trust-11/29/2009
2830Diamyd a VERY, very nice prey. The deal coming up soon might surprise the diabetB O Trust-11/29/2009
2829Cool, thanks for that.... had no idea that they had made religion of such listscaram(o)uche-11/18/2009
2828Merck no longer specifically calls out 5HT2c as not being desired: merck.com Stommysdad-11/16/2009
2827WSJ: Merck’s Dick Clark Has Opportunities, but All Are Risky By Deal Journal Jacmopgcw-11/16/2009
2826Trimeris deal is in trouble.... Trimeris Receives Request from Arigene for Exterkrw-11/12/2009
2825Should actually belong here >> Message 26092271RockyBalboa-11/12/2009
2824>> just call me chicken? << I'll continue with "smart"scaram(o)uche-11/5/2009
2823Hey Rick- For my VVUS position, when it kept dropping after I picked up my secoBiotech Jim-11/5/2009
2822You've been buying VVUS........ if you followed through on what you said scaram(o)uche-11/5/2009
2821<Health Blog Question of the Day: Who will Merck buy next?> They should bBiotech Jim111/5/2009
2820>>Some pukin' private company that we've never heard of<< Tnigel bates-11/5/2009
2819>> Health Blog Question of the Day: Who will Merck buy next? << Somscaram(o)uche211/4/2009
2818Merck CEO ‘Actively Looking’ for Biotech Deals. November 4sim1-11/4/2009
2817I don't know but it does represent a change in strategy. So maybe some largerkrw-10/27/2009
2816which is why I dumped the stock that i got with pcop. i still like the potentiamopgcw-10/27/2009
2815Indeed - but given how little they have been paying, it's not quite cause annigel bates-10/27/2009
2814LGND stock has been killed since they embarked on this roll up strategy.rkrw-10/27/2009
2813How much it's worth is questionable, but they certainly haven't paid mucnigel bates-10/27/2009
2812Ligand has acquired PCOP, NRGN and now MBRX. Consolidating failed chemistry comprkrw-10/27/2009
2811NOVATO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (nigel bates-10/27/2009
2810Proximagen signs Letter of Intent to acquire Cambridge Biotechnology fnigel bates-10/22/2009
2809I think people were worried about someone one a whole lot worse and more expensirkrw-10/12/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News